Abstract:Humans are exposed to a huge amount of environmental pollutants called endocrine disrupting chemicals (EDCs). These molecules interfere with the homeostasis of the body, usually through mimicking natural hormones leading to activation or blocking of their receptors. Many of these compounds have been associated with a broad range of diseases including the development or increased susceptibility to breast cancer, the most prevalent cancer in women worldwide, according to the World Health Organization. Thus, this article presents a virtual high-throughput screening (vHTS) to evaluate the affinity of proteins related to breast cancer, such as ESR1, ERBB2, PGR, BCRA1, and SHBG, among others, with EDCs from urban sources. A blind docking strategy was employed to screen each protein-ligand pair in triplicate in AutoDock Vina 2.0, using the computed binding affinities as ranking criteria. The three-dimensional structures were previously obtained from EDCs DataBank and Protein Data Bank, prepared and optimized by SYBYL X-2.0. Some of the chemicals that exhibited the best affinity scores for breast cancer proteins in each category were 1,3,7,8-tetrachlorodibenzo-p-dioxin, bisphenol A derivatives, perfluorooctanesulfonic acid, and benzo(a)pyrene, for catalase, several proteins, sex hormone-binding globulin, and cytochrome P450 1A2, respectively. An experimental validation of this approach was performed with a complex that gave a moderate binding affinity in silico, the sex hormone binding globulin (SHBG), and bisphenol A (BPA) complex. The protein was obtained using DNA recombinant technology and the physical interaction with BPA assessed through spectroscopic techniques. BPA binds on the recombinant SHBG, and this results in an increase of its α helix content. In short, this work shows the potential of several EDCs to bind breast cancer associated proteins as a tool to prioritize compounds to perform in vitro analysis to benefit the regulation or exposure prevention by the general population.

[Assessment of the Estrogenicity of Endosulfan and Other Chemicals with the in Vitro Proliferation of Human Breast Cancer Cell]

QSAR Study of Endocrine Disrupting Chemicals

Ultrasensitive Electrochemical Biosensor for Rapid Screening of Chemicals with Estrogenic Effect

Assessment of Estrogenic Activity of Natural Compounds Using Improved E-screen Assay

Soil screening for identifying ecological risk stressors using a battery of in vitro cell bioassays.

Facile Screening of Potential Xenoestrogens by an Estrogen Receptor-Based Reusable Optical Biosensor.

Assessment of Endocrine-Disrupting Effects of Emerging Polyhalogenated Carbazoles (phczs): in Vitro, in Silico, and in Vivo Evidence

The response of electrochemical method to estrogen effect and the tolerance to culture factors: Comparison with MTT and cell counting methods

Application of Estrogen Receptor Binding Assay in the Endocrine Disrupting Chemicals Screening Tests

Bioassay and Application of Environmental Estrogens

Assessing Estrogenic Activities of Selected Endocrine Disrupting Chemicals and Their Combination Effects

Rapid and ultrasensitive detection of endocrine disrupting chemicals using a nanosensor-enabled cell-based platform.

Novel, Highly Sensitive, in Vivo Screening Method Detects Estrogenic Activity at Low Doses of Bisphenol A.

A Novel ERα-mediated Reporter Gene Assay for Screening Estrogenic/antiestrogenic Chemicals Based on LLC-MK2 Cells.

Assessment of Estrogen Disrupting Potency in Animal Foodstuffs of China by Combined Biological and Chemical Analyses

Electrochemical Biosensor for Estrogenic Substance Using Lipid Bilayers Modified by Au Nanoparticles

COMBINED TOXIC EFFECTS OF FIVE ESTROGENS ASSESSED BY YEAST ESTROGEN SCREEN ASSAY

An Integrated "4-Phase" Approach for Setting Endocrine Disruption Screening Priorities--phase I and II Predictions of Estrogen Receptor Binding Affinity

Estrogenic Effect Of Organic Extract From Water Source Of X City

Study on Biological Screening Assay and Toxicology of Endocrine Disruptors in Water

Urban Endocrine Disruptors Targeting Breast Cancer Proteins